Foghorn Therapeutics (FHTX) Loses -23.05% in 4 Weeks, Here's …

1 day ago · Foghorn Therapeutics Inc. (FHTX) has been beaten down lately with too much selling pressure. While the stock has lost 23.1% over the past four weeks, there is light at the end of …

05%
OFF

Foghorn Therapeutics (FHTX) Loses -23.05% In 4 Weeks, Here's …

1 week from now

1 day ago · Foghorn Therapeutics Inc. (FHTX) has been beaten down lately with too much selling pressure. While the stock has lost 23.1% over the past four weeks, there is light at the end of …

nasdaq.com

17%
OFF

After Plunging -30.17% In 4 Weeks, Here's Why The Trend Might …

1 week from now

Dec 12, 2024 · Foghorn Therapeutics Inc. (FHTX) has been beaten down lately with too much selling pressure. While the stock has lost 30.2% over the past four weeks, there is light at the …

yahoo.com

08%
OFF

Foghorn Therapeutics Inc. - MarketWatch

1 week from now

Jan 6, 2025 · Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why Nov. 29, 2024 at 12:00 p.m. ET on Zacks.com Wall Street Analysts See a 104.08% Upside in Foghorn Therapeutics …

marketwatch.com

17%
OFF

Foghorn Therapeutics Inc. (FHTX) - Yahoo Finance

1 week from now

After Plunging -30.17% in 4 Weeks, Here's Why the Trend Might Reverse for Foghorn Therapeutics (FHTX) The heavy selling pressure might have exhausted for Foghorn …

yahoo.com

05%
OFF

FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Misses …

1 week from now

May 6, 2024 · Foghorn Therapeutics (FHTX) Loses -23.05% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks 14h Foghorn Therapeutics Highlights Program …

businessinsider.com

$0.31
OFF

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses …

1 week from now

Nov 4, 2024 · Foghorn Therapeutics Inc. (FHTX Quick Quote FHTX - Free Report) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of …

zacks.com

17%
OFF

Foghorn Therapeutics Inc. (FHTX) - Yahoo Finance

1 week from now

Find the latest Foghorn Therapeutics Inc. (FHTX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... After Plunging -30.17% in 4 …

yahoo.com

05%
OFF

Foghorn Therapeutics (FHTX) Loses -23.05% In 4 Weeks, Here's …

1 week from now

2 days ago · Foghorn Therapeutics Inc. (FHTX Quick Quote FHTX - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 23.1% over the …

zacks.com

17%
OFF

Foghorn Therapeutics Inc. (FHTX) - Yahoo Finance

1 week from now

After Plunging -30.17% in 4 Weeks, Here's Why the Trend Might Reverse for Foghorn Therapeutics (FHTX) Zacks • 22 days ago Foghorn Therapeutics (FHTX) Upgraded to Buy: …

yahoo.com

05%
OFF

Foghorn Therapeutics Price Target Lowered To $4 From $9 At …

1 week from now

Dec 18, 2024 · Foghorn Therapeutics (FHTX) Loses -23.05% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks 20h Foghorn Therapeutics Highlights Program …

businessinsider.com

$13
OFF

Foghorn Therapeutics Price Target Lowered To $13 From $20 At H.C ...

1 week from now

Dec 17, 2024 · H.C. Wainwright lowered the firm’s price target on Foghorn Therapeutics (FHTX) to $13 from $20 and keeps a Buy rating on the shares after the company announced the …

businessinsider.com

$4
OFF

Foghorn Therapeutics Price Target Lowered To $4 From $9 At

1 week from now

Dec 18, 2024 · Morgan Stanley analyst Vikram Purohit lowered the firm’s price target on Foghorn Therapeutics (FHTX) to $4 from $9 and keeps an Equal Weight rating on the shares. The firm …

nasdaq.com

$0.31
OFF

Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Misses …

1 week from now

Nov 4, 2024 · Foghorn Therapeutics Inc. (FHTX) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.34 per …

yahoo.com

FAQs about Foghorn Therapeutics (FHTX) Loses -23.05% in 4 Weeks, Here's … Coupon?

Should you buy Foghorn Therapeutics Inc (fhtx)?

Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. ...

Who owns Foghorn Therapeutics Inc?

The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA. FHTX | Complete Foghorn Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Will Foghorn Therapeutics (fhtx) move higher on growing optimism?

Foghorn Therapeutics (FHTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). ...

What is the consensus EPS estimate for Foghorn Therapeutics (fhtx)?

The current consensus EPS estimate is -$0.46 on $11.3 million in revenues for the coming quarter and -$1.88 on $31.3 million in revenues for the current fiscal year. Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of 26.19% and 3.27%, respectively, for the quarter ended September 2024. ...

When is Foghorn Therapeutics's next earnings date?

Earnings for Foghorn Therapeutics are expected to grow in the coming year, from ($2.81) to ($2.40) per share. Foghorn Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 14th, 2023 based off prior year's report dates. When is Foghorn Therapeutics's earnings date? ...

Is Foghorn Therapeutics (fog) a good stock to buy?

Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Foghorn Therapeutics: unfavorable. ...